🇺🇸 fenofibrate and tibolone in United States

FDA authorised fenofibrate and tibolone on 31 December 1993

Marketing authorisation

FDA — authorised 31 December 1993

  • Application: NDA019304
  • Marketing authorisation holder: ABBVIE
  • Local brand name: LIPIDIL
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

Frequently asked questions

Is fenofibrate and tibolone approved in United States?

Yes. FDA authorised it on 31 December 1993.

Who is the marketing authorisation holder for fenofibrate and tibolone in United States?

ABBVIE holds the US marketing authorisation.